Securities Registration (section 12(b)) (8-a12b)
August 10 2017 - 1:45PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-A
FOR REGISTRATION OF CERTAIN CLASSES
OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g)
OF THE
SECURITIES EXCHANGE ACT OF 1934
PRESSURE
BIOSCIENCES, INC.
(Exact name of registrant as specified
in its charter)
Massachusetts
|
|
04-2652826
|
(State of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
14 Norfolk Avenue
South Easton, Massachusetts 02375
Tel: (508) 230-1828
|
(Address of principal executive offices)
|
Securities to be registered pursuant
to Section 12(b) of the Act:
Title of each class to be so
registered
|
|
Name of each exchange on which
each class is to be registered
|
Common Stock, $0.01 par value per share
|
|
The NASDAQ Stock Market LLC
|
|
|
|
Common Stock Purchase Warrants
|
|
The NASDAQ Stock Market LLC
|
If this form relates to the registration
of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c),
check the following box. [X]
If this form relates to the registration
of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d),
check the following box. [ ]
Securities Act registration statement
file number to which this form relates:
333-215277
Securities to be registered pursuant
to Section 12(g) of the Act:
None
INFORMATION REQUIRED IN REGISTRATION
STATEMENT
Item 1. Description of Registrant’s Securities to
be Registered.
The description of the common stock,
$0.01 par value per share (the “Common Stock”), of Pressure BioSciences, Inc., a Massachusetts corporation (the “Registrant”)
set forth under the heading “Description of Capital Stock” contained in the prospectus included in the Registrant’s
registration statement on Form S-1 (File No. 333
-
215277), as amended (the “Registration Statement”), filed under
the Securities Act of 1933, as amended (the “Securities Act”), with the Securities and Exchange Commission (the “Commission”)
is incorporated herein by reference. Any form of prospectus subsequently filed by the Registrant with the Commission pursuant to
Rule 424(b) under the Securities Act that constitutes part of the Registration shall be deemed to be incorporated herein by reference.
Item 2. Exhibits.
In accordance with the “Instructions
as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because
no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not
being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.
|
PRESSURE BIOSCIENCES, INC.
|
|
|
|
Date: August 10, 2017
|
By:
|
/s/
Richard T. Schumacher
|
|
Name:
|
Richard T. Schumacher
|
|
Title:
|
Chief Executive Officer
|
Pressure Biosciences (CE) (USOTC:PBIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pressure Biosciences (CE) (USOTC:PBIO)
Historical Stock Chart
From Sep 2023 to Sep 2024